A new Australian clinical trial is offering hope to children and adolescents with some of the most aggressive and treatment-resistant brain tumours.
Join us for one of our popular pre-conference workshops, held on Day 1 of the 2025 ANZCHOG ASM in Brisbane on Wednesday, 30 July.
Nominations are now open for the ANZCHOG Life Membership Award. This award is given to those who have exhibited distinguished and exceptional service to ANZCHOG.
This Brain Cancer Awareness Month, discover more about the new CoACT: Brain Cancer (the Consortium for Australian Children’s Trials in Brain Cancer).
ANZCHOG congratulates Associate Professor Maria McCarthy, Chair of our Psycho-oncology Group, who was appointed as a Member of the Order of Australia (AM) in this year’s King’s Birthday honours.
A new chapter begins at ANZCHOG, as Associate Professor Andy Moore steps into the role of our Board Chair, following the outstanding leadership of Professor Nick Gottardo.
Great news this week with the funding announcement for CoACT-Brain Cancer (The Consortium for Australian Children’s Trials in Brain Cancer), a national clinical trial consortium dedicated to improving outcomes for
A new funding partnership unites six leading philanthropic organisations to support the ambitious TarGeT trial, a cutting-edge international study that uses precision medicine to deliver treatments tailored to each patient’s
New research has been published from our very own ANZCHOG Nursing Research Group, highlighting the key factors shaping job satisfaction among Australia’s paediatric cancer nurses and the need for greater
